Background The etiopathogenesis of coronavirus disease 2019 (COVID-19) stem partially from the abnormal activation of the innate and adaptive immune systems. Here in the current …
JMB Santos, CP Soares, FR Monteiro, R Mello… - Frontiers in …, 2021 - frontiersin.org
Likely as in other viral respiratory diseases, SARS-CoV-2 elicit a local immune response, which includes production and releasing of both cytokines and secretory immunoglobulin …
M Gajate-Arenas, O García-Pérez… - Frontiers in Cellular …, 2023 - frontiersin.org
COVID-19 is characterized by a wide range of symptoms where the genetic background plays a key role in SARS-CoV-2 infection. In this study, the relative expression of IRF9 …
L Quartuccio, M Fabris, A Sonaglia, M Peghin… - Cytokine, 2021 - Elsevier
Background Patients infected by SARS-CoV-2 can develop interstitial pneumonia, requiring hospitalisation or mechanical ventilation. Increased levels of inflammatory biomarkers are …
Aberrant activation of the immune system has been attributed with etiology and pathogenesis of coronavirus disease 2019 (COVID-19). Here, the transcript levels of toll-like …
Abstract Background Coronavirus disease 2019 (COVID-19) is a new respiratory and systemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
H Shuai, H Chu, Y Hou, D Yang, Y Wang, B Hu… - Journal of Infection, 2020 - Elsevier
Objectives Respiratory and intestinal tract are two primary target organs of SARS-CoV-2 infection. However, detailed characterization of the host-virus interplay in infected human …
C Colarusso, A Maglio, M Terlizzi, C Vitale, A Molino… - Biomedicines, 2021 - mdpi.com
Purpose: SARS-CoV-2 infection induces in some patients a condition called long-COVID-19, herein post-COVID-19 (PC), which persists for longer than the negative oral-pharyngeal …
K Nagaoka, H Kawasuji, Y Murai, M Kaneda… - Frontiers in …, 2022 - frontiersin.org
Background The role of type I interferons (IFNs) in the early phase of COVID-19 remains unclear. Objectives To evaluate the relationship between IFN-I levels in patients with COVID …